Literature DB >> 20191205

Fatal disseminated mucormycosis in a patient with mantle cell non-Hodgkin's lymphoma: an autopsy case.

Inci Alacacioglu1, Aydanur Kargi, Mehmet Ali Ozcan, Ozden Piskin, Cilem Solak, Mustafa Secil, Mehtat Unlu, Fatih Demirkan, Guner Hayri Ozsan, Bulent Undar.   

Abstract

A patient with mantle cell non-Hodgkin's lymphoma presented herself with fever, nausea, right upper quadrant pain on the 7th day of R-CHOP chemotherapy. After hospitalization with the suspicion of acute cholecystitis, she received antibiotherapy with G-CSF because of emerging neutropenia at the 10th day of chemotherapy. Abdominal computed tomography revealed small infarcts in the spleen and kidneys. The ecchymotic lesion which developed on her right lateral malleolus, became bullous in the following days and treated as ecthyma gangrenosum. Although the patient was afebrile with a normal neutrophil count on the third day of antibiotherapy, she developed acute renal failure and deteriorated rapidly. The patient underwent hemodialysis but expired on the 10th day of hospitalization. Post mortem autopsy findings showed ischemic infarction and necrosis of parenchyma due to mycotic thrombosis of arteries and veins of many organs (heart, lung, diaphragm, kidneys, spleen, gut mucosa) as well as invasion of vessel walls and parenchyma by mucor. We reviewed mucormycosis in the light of this case.

Entities:  

Mesh:

Year:  2009        PMID: 20191205     DOI: 10.1590/s1413-86702009000300017

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  2 in total

1.  Fatal disseminated mucormycosis in an immunocompotent patient: a case report and literature review.

Authors:  Amir Hossein Sarrami; Mehrdad Setareh; Masoud Izadinejad; Noushin Afshar-Moghaddam; Mohammad Mehdi Baradaran-Mahdavi; Mohsen Meidani
Journal:  Int J Prev Med       Date:  2013-12

2.  Disseminated mucormycosis (DM) after pneumonectomy: a case report.

Authors:  Qian Wang; Bo Liu; Youde Yan
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.